ACAT
NP Life Sciences Health Industry Group Inc.
Key Financials
Net Income
$-2935
↑ 84.4%
Operating Income
$-690
↑ 96.3%
Revenue
$164621
↑ 61.4%
EPS (Diluted)
$0.00
NaN%
Total Assets
$76864.00
↓ 39.8%
Total Liabilities
$60483.00
↓ 44.2%
Shareholders' Equity
$19316.00
↓ 49.4%
Cash & Equivalents
$70614.00
↓ 42.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 8/21/2024 | View on SEC |
| 15-12G | 5/15/2024 | View on SEC |
| 10-K | 4/16/2024 | View on SEC |
| NT 10-K | 4/2/2024 | View on SEC |
| 10-Q | 11/14/2023 | View on SEC |
| 10-Q | 8/14/2023 | View on SEC |
| 10-Q | 5/15/2023 | View on SEC |
| 10-K | 4/18/2023 | View on SEC |
| NT 10-K | 4/3/2023 | View on SEC |
| DEF 14C | 11/30/2022 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ACAT |
| Company Name | NP Life Sciences Health Industry Group Inc. |
| CIK | 1781726 |
| Sector | Services-Educational Services |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 8200 |
| SIC Description | Services-Educational Services |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | (925)-362-3169 |